Atrys Health, S.A. (BME:ATRY)
3.390
+0.020 (0.59%)
Oct 28, 2025, 1:41 PM CET
Atrys Health Revenue
Atrys Health had revenue of 117.50M EUR in the half year ending June 30, 2025, with 12.60% growth. This brings the company's revenue in the last twelve months to 226.24M, up 7.17% year-over-year. In the year 2024, Atrys Health had annual revenue of 218.10M with 5.82% growth.
Revenue (ttm)
226.24M
Revenue Growth
+7.17%
P/S Ratio
1.10
Revenue / Employee
112.22K
Employees
2,045
Market Cap
248.87M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 218.10M | 12.00M | 5.82% |
| Dec 31, 2023 | 206.10M | 42.90M | 26.28% |
| Dec 31, 2022 | 163.20M | 39.35M | 31.77% |
| Dec 31, 2021 | 123.85M | 90.04M | 266.34% |
| Dec 31, 2020 | 33.81M | 17.15M | 102.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.45B |
| Almirall | 1.05B |
| Laboratorios Farmaceuticos Rovi | 749.00M |
| Faes Farma | 543.77M |
| Laboratorio Reig Jofre | 336.87M |
| Clínica Baviera | 288.92M |
| Prim, S.A. | 240.68M |
| Pharma Mar | 189.27M |